A carregar...

Body composition and aspirin dose for colorectal adenoma prevention in a randomized clinical trial

BACKGROUND: Visceral adiposity is a risk factor for colorectal adenomas, and aspirin is an established chemopreventive agent. Evidence from clinical trials suggests the effectiveness of aspirin at preventing cardiovascular disease and cancer may require higher doses for higher body weight. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Epidemiol Biomarkers Prev
Main Authors: Passarelli, Michael N., Barry, Elizabeth L., Rees, Judy R., Mott, Leila A., Ahnen, Dennis J., Baron, John A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6608598/
https://ncbi.nlm.nih.gov/pubmed/31263057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!